Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's Lymphoma

NCT00308087 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

75

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated by sponsor due to low enrollment; see details below

Conditions

Lymphoma, Follicular

Interventions

DRUG: Sargramostim (Leukine)
DRUG: Rituximab

Sponsor

Genzyme, a Sanofi Company